The Journal of Sexual Medicine, Sexual Medicine Reviews, and Sexual Medicine to be published by Elsevier
Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced that it has been selected by the International Society for Sexual Medicine (ISSM) to publish its flagship journal, The Journal of Sexual Medicine, as well as Sexual Medicine Reviews and open access journal Sexual Medicine, as of January 2016.
The Journal of Sexual Medicine (JSM) is the premier, authoritative publication in the field, publishing high-impact multidisciplinary basic and clinical science in monthly issues. Sexual Medicine Reviews is a quarterly journal, commissioning evidence-based reviews in order to synthesize clinical and translational research to distill the best available evidence in the field. Sexual Medicine is ISSM's most recent publication. Launched in 2014 as an OA journal, it ensures rapid dissemination of multidisciplinary clinical and basic research in all areas of global sexual medicine.
John P. Mulhall, Editor-in-Chief of The Journal of Sexual Medicine, said, "The JSM editorial team is delighted to work with Elsevier. As a giant in scientific and medical publishing with a proven track record in urology and reproductive health, we are very pleased to add our sexual medicine content to Elsevier's journal program and to its electronic platforms to ensure the highest level of readability and interactivity for our readers. I personally look forward to ensuring that JSM brings research of the highest relevance, rigor, and reproducibility to our readership."
"We are excited about this opportunity to enhance our health sciences journal portfolio with the inclusion of these three prestigious journals in the field of sexual medicine. We look forward to working together with the ISSM and the editorial teams to ensure continued growth and enhance global exposure of the journals," said Anne Kitson, Executive Vice President, Health and Medical Science Journals at Elsevier.
Patient-derived organoids: Transforming cancer research and personalized medicine